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Figure S1. Hourly profile (8:00-00:00, n=17) of chiral drug concentration and enantiomeric 
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Figure S2.  Daily concentrations and enantiomeric fraction of chiral micropollutants in 
influent wastewater over 8 d in December 2014 collected as 24 h volume paced composites. 
Table S1. Chemical information of micropollutants studied 
Table S2.  Method performance data for LC-MS/MS methods 
Table S3.  Repeatability of sample volume collected by automated sampler using a 5 ft 
suction line and a single rinse cycle (n=100) 
Table S4. Measured variables during influent and effluent wastewater sampling campaigns. 
Table S5. Loss of micropollutants in water stored in polypropylene bottles at 18 ⁰C and 4 ⁰C 
over a 24 h time period (n=2). Underlined values show those out with ±20 % significance 
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Table S6. Stability (%) of micropollutants in collected influent and effluent wastewater stored 
at 18 ⁰C and 4 ⁰C over a 24 hour time period (n=2). Underlined values show those out with 
±20 % significance level 
Table S7.  Stability (%) of micropollutants in collected influent and effluent wastewater 
stored with the addition of NaN3 (1 g L-1) at 18 ⁰C and 4 ⁰C over a 24 hour time period (n=2). 
Underlined values show those out with ±20 % significance level 
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Table S8. Stability (%) of micropollutants in collected influent and effluent wastewater stored 
at pH 2 at 18 ⁰C and 4 ⁰C over a 24 hour time period (n=2). Underlined values show those out 
with ±20 % significance level 
Table S9.  Difference in micropollutant concentration (%) of influent and effluent wastewater 
daily composites collected in a time paced versus a volume paced manner (n=3). Underlined 
values show those out with ±20 % significance level 
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Figure S1. Hourly profile (8:00-00:00, n=17) of chiral drug concentration and enantiomeric 





















































































































































































































































































































Figure S2.  Daily concentrations and enantiomeric fraction of chiral micropollutants in influent 
wastewater over 8 d in December 2014 collected as 24 h volume paced composites. Fluoxetine graph 











































































































































































































































































(mg L-1) i 












(Most basic)viii  
UV filters Benzophenone-1 C13H10O3 - 413.4 2.96 2.65E-11 2.90 2.65E-11 2.84E-07 7.72±0.35 - 
 Benzophenone-2 C13H10O5 - 398.5 2.78 3.61E-16 2.35 3.61E-16 6.69E-12 6.98±0.35 - 
 Benzophenone-3 C14H12O3 - 68.6 3.52 1.50E-08 3.06 1.50E-08 5.26E-06 7.56±0.35 - 
 Benzophenone-4 C14H12O6S - 2.03E+04 0.37 7.03E-15 -0.53 7.06E-15 - -0.70±0.50 - 
Parabens Methylparaben C8H8O3 - 5.98E+03 2.00 2.23E-09 1.63 3.61E-09 5.55E-03 8.31±0.13 - 
 Ethylparaben C9H10O3 - 1.89E+03 2.49 3.01E-09 1.99 4.79E-09 7.59E-04 8.31±0.13 - 
 Propylparaben C10H12O3 - 529.3 2.98 4.25E-09 2.51 4.25E-12 9.30E-04 8.23±0.15 - 
 Butylparaben C11H14O3 - 159.0 3.47 6.00E-009 2.96 6.00E-09 3.56E-04 8.22±0.15 - 
Plasticizer Bisphenol-A C15H16O2 - 172.7 3.64 9.16E-12 4.04 9.16E-12 5.34E-07 10.29±0.10 - 
Steroid estrogens E1 C18H22O2 - 146.8 3.43 3.80E-10 4.31 3.80E-10 1.54E-08 10.25±0.40 - 
 E2 C18H24O2 84 82.0 3.94 1.41E-12 3.74 1.41E-12 9.82E-09 10.27±0.60 - 
 EE2 C20H24O2 12 116.4 4.12 7.94E-12 3.90 7.94E-12 3.74E-09 10.24±0.60 - 
Antibacterials/ 
antibiotics Sulfasalazine C18H14N4O5S 54,039 2.4 3.81 2.19E-18 -1.76 2.19E-18 5.95E-20 2.70±0.10 0.90±0.10 
 Clarithromycin C38H69NO13 16,508 0.3 3.18 1.73E-29 2.31 1.73E-29 5.06E-30 13.08±0.70 8.16±0.70 
 Azithromycin C38H72N2O12 1,965 6.20E-02 3.24 5.30E-29 -2.48 5.30E-29 2.51E-31 13.28±0.70 8.59±0.70 
 Trimethoprim C14H18N4O3 10,998 2.33E+03 0.73 2.39E-14 1.13 2.39E-14 3.74E-11 - 7.04±0.10 
 Sulfamethoxazole C10H11N3O3S - 3.94E+03 0.48 9.56E-13 -0.03 9.56E-13 1.87E-09 5.81±0.50 1.39±0.10 
 Triclosan C12H7Cl3O2 - 4.6 4.66 2.13E-08 4.76 2.13E-08 3.26E-05 7.80±0.35 - 
Hypertension Valsartan C24H29N5O3 6,484 1.4 3.65 1.82E-18 1.15 1.82E-18 1.06E-19 3.56±0.10 0.60±0.10 
 Irbesartan C25H28N6O 8,353 - - - 4.97 - 1.05E-16 4.16±0.10 2.60+0.20 
 Lisinopril C21H31N3O5 4,799 8.6 -0.94 1.89E-22 -3.23 1.89E-22 1.14E-18 2.18±0.10 10.50±0.10 
NSAIDS Ketoprofen C16H14O3 243 120.4 3.00 2.12E-11 0.08 2.12E-11 3.32E-08 4.23±0.10 - 
 Ibuprofen C13H18O2 108,435 41.1 3.79 1.52E-07 1.25 1.52E-07 1.39E-04 4.41±0.10 - 
 Naproxen C14H14O3 126,258 144.9 3.10 3.39E-10 -0.54 3.39E-10 3.01E-07 4.84±0.30 - 
 Diclofenac C14H11Cl2NO2 10,652 4.5 4.02 4.73E-12 0.73 4.73E-12 1.59E-07 4.18±0.10 -2.26±0.50 
 Acetaminophen C8H9NO2 >2,000,000 3.04E+04 0.27 6.42E-13 0.90 6.42E-13 1.43E-06 9.86±0.13 1.72±0.50 
Lipid regulators Bezafibrate C19H20ClNO4 7,966 1.2 4.25 2.12E-15 0.46 2.12E-15 6.29E-14 3.29±0.10 -2.06±0.70 
 Atorvostatin C33H35FN2O5 13,937 1.12E-03 6.36 2.41E-23 1.86 2.41E-23 6.84E-22 4.29±0.10 0.38±0.50 
Antihistamines Fexofenadine C32H39NO4 8,715 2.36E-02 2.81 1.19E-18 2.93 1.19E-18 2.08E-20 4.43±0.10 9.42±0.10 
 Cetirizine C21H25ClN2O3 1,612 1.1 -0.61 4.19E-17 0.69 4.19E-17 1.39E-12 3.46±0.10 6.71±0.10 
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Diabetes Metformin C4H11N5 - 1.00E+06 -2.64 7.64E-16 -6.45 7.64E-16 1.33 - 12.27±0.10 
 Gliclazide C15H21N3O3S 35,194 138.4 2.12 7.95E-13 0.79 7.95E-13 - 6.07±0.10 3.89±0.20 
Cough suppressant Pholcodine C23H30N2O4 600 1.01E+04 0.59 3.42E-19 -0.48 3.42E-19 3.44E-14 13.40±0.20 8.22±0.40 
Beta-blocker Atenolol C14H22N2O3 20,725 685.2 -0.03 1.37E-18 -1.71 1.37E-18 3.82E-11 13.88±0.20 9.43±0.10 
 Metoprolol C15H25NO3 2,311 4.77E+03 1.69 1.40E-13 -0.38 1.40E-13 4.52E-07 13.89±0.20 9.43±0.10 
 Propranolol C16H21NO2 9,076 228.0 2.60 7.98E-13 0.45 7.98E-13 2.48E-08 13.84±0.20 9.50±0.30 
H2 receptor agonists Ranitidine C13H22N4O3S 35,665 2.47E+04 0.29 3.42E-15 -1.56 3.42E-15 7.66E-08 - 8.35±0.28 
 Cimetidine C10H16N6S 3,195 1.05E+04 0.57 9.55E-16 -0.30 9.55E-16 3.13E-09 14.13±0.10 7.07±0.61 
X-ray contrast media Iopromide C18H24I3N3O8 - 23.8 -2.49 1.00E-028 -0.44 1.00E-28 5.00E-30 10.62±0.70 -2.60±0.70 
Drug precursor and 
metabolite 
Ephedrine/ 
pseudoephedrine C10H15NO 622 7.15E+04 0.68 8.65E-11 -1.13 8.65E-11 8.65E-03 13.96±0.20 9.38±0.10 
 Norephedrine C9H13NO - 1.49E+05 0.22 3.94E-11 -1.40 3.94E-11 1.10E-03 12.07±0.45 8.47±0.10 
Anti-cancer Azathioprine C9H7N7O2S 2,768 272.3 -0.09 2.64E-15 1.21 2.64E-15 5.94E-11 - 7.47±0.20 
 Methotrexate C20H22N8O5 126 2.60E+03 -1.28 1.54E-31 -7.06 1.54E-31 - 3.47±0.10 5.56±0.10 
 Ifosfamide C7H15Cl2N2O2P - 3.78E+03 0.97 1.36E-11 0.10 1.36E-11 1.15E-04 - 1.44±0.20 
 Tamoxifen C26H29NO 453 0.2 6.30 4.49E-10 5.07 4.49E-10 1.85E-09 - 8.69±0.28 
Anaesthetic and 
metabolite Ketamine C13H16ClNO 64 3.87E+03 3.12 1.38E-08 3.18 1.38E-08 1.76E-05 - 6.46±0.20 
 Norketamine C15H11ClN2O - - - - 2.71 1.78E-10 1.26E-05 - 6.25±0.20 
Anti-depressants and 
metabolites Venlafaxine C17H27N1O2 16,211 266.7 3.28 2.87E-11 1.32 2.87E-11 4.92E-07 14.84±0.20 9.26±0.28 
 Desmethylvenlafaxine C16H25NO2 - - - - 1.17 - 3.03E-07 10.04±0.26 9.33±0.28 
 Fluoxetine C17H18F3NO 5,319 60.3 4.65 8.90E-08 1.92 8.90E-08 1.88E-06 - 10.05±0.10 
 Norfluoxetine C16H16F3NO - - - - 1.54 - 5.21E-06 - 9.05±0.13 
 Sertraline C17H17Cl2N 11,429 3.5 5.29 5.10E-08 3.11 5.10E-08 3.85E-07 - 9.47±0.40 
 Mirtazapine C17H19N3 3,239 - - - 3.15 - 1.11E-07 - 8.10±0.20 
 Citalopram C20H21FN2O 8,878 31.1 3.74 2.69E-11 1.50 2.69E-11 1.53E-07 - 9.57±0.28 
 Desmethylcitalopram C19H19FN2O - - - - 0.14 - 1.40E-07 - 10.50±0.10 
Anti-epileptic and 
metabolites Carbamazepine C15H12N2O 44,498 17.7 2.25 1.08E-10 2.77 1.08E-10 5.78E-07 13.94±0.20 -0.49±0.20 
 Carbamazepine10,11-epoxide C15H12N2O2 - - - - 1.97 - 2.69E-06 13.91±0.20 -0.50±0.20 
 10,11-Dihydro-10-hydroxycarbamazepine C15H14N2O2 - - - - 1.73 - 3.33E-08 13.75±0.20 -0.53±0.40 
Calcium channel 
blocker Diltiazem C22H26N2O4S 21,922 12.3 2.79 8.61E-17 1.97 8.61E-17 4.27E-14 - 8.94±0.28 
Hypnotic Temazepam C16H13ClN2O2 833 163.9 2.15 1.13E-08 2.79 1.13E-08 6.33E-13 11.66±0.40 1.58±0.50 
Anti-psychotic Quetiapine C21H25N3O2S 9,155 0.6 3.17 7.45E-18 2.67 7.45E-18 3.22E-13 14.41±0.10 6.74±0.10 
Veterinary Tylosin C46H77NO17 - 0.5 1.05 5.77E-38 2.14 5.77E-38 0 13.06±0.70 7.39±0.70 
Human indicators 
and metabolites Creatinine C4H7N3O - 1.66E+05 -1.21 2.42E-12 -1.07 2.42E-12 0.313 - 6.89±0.20 
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 Nicotine C10H14N2 442 1.00E+06 1.00 3.00E-09 -2.34 3.00E-09 0.0303 - 8.00±0.50 
 Caffeine C8H10N4O2 - 2.63E+03 0.16 3.58E-11 -0.55 3.58E-11 3.72E-07 - 0.52±0.70 
 Cotinine C10H12N2O - 9.99E+05 0.34 3.33E-12 0.21 3.33E-12 4.21E-04 - 4.72±0.12 
 1,7 dimethylxantine C7H8N4O2 4 4.14E+03 -0.39 1.75E-12 0.24 1.75E-12 - 8.50±0.50 0.21±0.70 
Analgesics and 
metabolites Morphine C17H19NO3 5,684 2.64E+04 0.72 1.33E-16 -0.37 1.33E-16 7.06E-10 9.48±0.40 8.25±0.40 
 Dihydromorphine C17H21NO3 - 2.38E+04 0.93 1.51E-16 -0.26 1.51E-16 7.65E-10 9.56±0.40 8.44±0.40 
 Normorphine C16H17NO3 - 2.56E+05 0.50 6.07E-17 -2.05 6.07E-17 2.99E-10 9.17±0.40 9.54±0.40 
 Methadone C21H27NO 1,687 48.5 4.17 4.97E-10 3.39 4.97E-10 2.20E-07 - 9.50±0.50 
 EDDP C20H23N - - - - 2.50 - 2.06E-06 - 7.71±0.60 
 Codeine C18H21NO3 34,626 1.22E+04 1.28 7.58E-14 -0.23 7.58E-14 2.47E-09 13.40±0.20 8.23±0.40 
 Norcodeine C17H19NO3 - 3.92E+04 1.07 3.45E-14 -2.28 3.45E-14 1.51E-09 13.34±0.20 9.28±0.40 
 Dihydrocodeine C18H23NO3 9,720 6.53E+03 1.49 8.61E-14 -0.11 8.61E-14 2.48E-09 14.22±0.20 8.43±0.40 
 Tramadol C16H25NO2 41,445 1.15E+03 3.01 1.54E-11 0.72 1.54E-11 1.02E-06 14.47±0.40 9.61±0.28 
 N-desmethyltramadol C15H23NO2 - - - - -0.27 - 9.16E-06 14.46±0.40 10.56±0.10 
 O-desmethyltramadol C15H23NO2 - - - - 0.38 - 3.14E-07 10.00±0.10 9.61±0.28 
Stimulants and 
metabolites Amphetamine C9H13N1 - 2.80E+04 1.76 1.08E-06 -1.23 1.08E-06 0.307 - 9.94±0.10 
 Methamphetamine C10H15N - 1.33E+04 2.22 2.37E-06 -1.01 2.37E-06 0.147 - 10.38±0.10 
 MDMA C11H15NO2 - 7.03E+03 2.28 2.75E-09 -1.38 2.75E-09 3.17E-03 - 10.32±0.10 
 MDA C13H14N2 - 1.96E+03 2.18 1.58E-11 -1.61 1.58E-11 1.52E-06 - 5.32±0.25 
 Cocaine C17 H21NO4 - 1.30E+03 2.17 4.24E-11 0.92 4.24E-11 1.87E-06 - 8.97±0.60 
 Benzoylecgonine C16H19NO4 - 1.61E+03 -1.32 1.03E-13 -0.60 1.03E-13 1.32E-08 3.35±0.40 10.83±0.40 
 Anhydroecgonine methylester C10H15NO2 - - - - 0.21 - 0.0219 - 7.97±0.40 
 Cocaethylene C18H23NO4 - - - - 1.35 - 6.80E-07 - 9.04±0.60 
 Mephedrone C11H15NO - - - - 1.47 - 3.84E-03 - 7.41±0.10 
 MDPV C16H21NO3 - - - - 2.77 - 4.09E-07 - 8.41±0.20 
Opioid and 
metabolite Heroin C21H23NO5 - 2.15E+03 1.80 6.15E-13 -0.06 6.15E-13 7.38E-10 - 7.93±0.40 




Table S2.  Method performance data for LC-MS/MS methods 
Micropollutant Internal standard tr (min) EF 













Reverse-phased C18 – acidic compounds 
4-benzophenone Methylparaben 13C 6.94 - 101.9 7.83 25.84 122.8 5.78 19.09 
Sulfasalazine Naproxen D3 7.06 - 62.7 12.55 41.43 58.7 9.66 31.87 
Methylparaben Methylparaben 13C 7.50 - 99.8 0.28 1.41 100.8 0.19 0.94 
Valsartan Naproxen D3 7.64 - 101.1 7.24 23.90 79.9 6.40 21.12 
Ketoprofen Ketoprofen D3 7.74 - 45.4 0.36 1.82 40.3 0.34 1.68 
Bezafibrate Bezafibrate D6 7.87 - 91.4 0.64 2.11 92.9 0.38 1.25 
2-benzophenone Bisphenol A D16 7.89 - 107.2 2.38 11.90 109.2 1.60 8.00 
Naproxen Naproxen D3 8.11 - 82.7 6.29 31.45 98.0 1.17 5.85 
Ethylparaben Naproxen D3 8.32 - 87.5 0.49 1.61 83.5 0.46 1.52 
Fexofenadine Naproxen D3 8.38 - 107.3 0.56 1.85 83.8 0.40 1.32 
Irbesartan Bisphenol A D16 8.61 - 97.6 2.50 12.49 107.4 1.88 9.38 
Bisphenol A Bisphenol A D16 8.96 - 103.9 0.67 2.22 116.0 0.44 1.44 
Diclofenac Naproxen D3 9.04 - 112.2 0.85 2.79 100.7 0.56 1.84 
Propylparaben Bisphenol A D16 9.19  112.6 0.63 2.08 125.3 0.47 1.54 
Atorvastatin Naproxen D3 9.26 - 94.0 0.17 0.85 91.9 0.17 0.84 
1-benzophenone Ibuprofen D3 9.60 - 75.6 0.23 1.15 89.2 0.14 0.71 
E2 E2 (2,4,16,16 D4) 9.74 - 87.9 1.83 9.15 84.6 1.46 7.32 
Ibuprofen Ibuprofen D3 9.77 - 78.9 0.19 0.93 110.8 0.08 0.42 
EE2 E2 (2,4,16,16 D4) 9.80 - 106.6 1.84 9.22 87.9 1.41 7.03 
E1 E1 (2,4,16,16 D4) 9.82 - 99.1 1.96 9.78 92.7 1.54 7.69 
Butylparaben E1 (2,4,16,16 D4) 10.12 - 102.4 0.24 1.21 118.3 0.14 0.71 
Triclosan E1 (2,4,16,16 D4) 12.30 - 117.5 4.93 16.27 100.8 4.55 15.02 
Reverse-phased C18 – basic compounds 
Creatinine Metformin D6 2.73 - 46.9 945 3,118* 42.9 771* 2,544* 
Metformin Metformin D6 2.84 - 78.7 457* 1,509* 96.0 163* 460* 
Dihydromorphine Morphine D3 3.30 - 95.7 0.50 2.51 96.2 0.32 1.59 
Nicotine Atenolol D7 3.34 - 77.3 508* 2,296* 83.9 5.44 17.95 
Normorphine Morphine D3 3.41 - 109.5 9.99 32.96 106.5 7.84 25.88 
Anhydroecgonine methylester Atenolol D7 3.45 - 91.3 2.95 14.76 109.5 1.99 9.96 
Morphine Morphine D3 3.46 - 93.9 8.85 29.20 109.8 6.34 20.92 
Pholcodine Atenolol D7 3.70 - 42.0 25.25 83.32 102.0 8.02 26.45 
Atenolol Atenolol D7 4.32 - 88.6 0.71 2.35 109.7 0.56 1.84 
Ranitidine Atenolol D7 4.62 - 97.8 14.76 73.79 106.8 22.28 111.39 
Iopromide Acetaminophen D4 4.89 - 138.5 24.51 123 123.7 14.11 70.56 
Acetaminophen Acetaminophen D4 5.11 - 77.8 138* 1,017* 116.4 2.39 11.95 
Cimetidine Acetaminophen D4 5.32 - 123.7 5.06 25.32 106.2 3.12 15.59 
Dihydrocodeine Codeine D6 5.47 - 85.7 0.88 2.89 118.6 0.55 1.83 
Codeine Codeine D6 6.05 - 94.8 2.56 12.82 102.8 1.46 7.31 
Norephedrine 1S,2R-(+) Ephedrine D3 6.34 - 85.4 0.37 18.60 100.9 0.35 17.28 
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Norcodeine Codeine D6 6.45 - 95.7 8.53 28.15 87.5 8.32 27.44 
1,7 dimethylxanthine Cotinine D3 6.78 - 79.6 560* 2,165* 110.6 11.40 37.63 
Lisinopril Amphetamine D5 7.14 - 102.3 3.25 32.54 88.5 4.25 42.51 
Ephedrine/pseudoephedrine 1S,2R-(+) Ephedrine D3 7.22 - 92.8 1.32 4.36 88.6 1.62 5.36 
Cotinine Cotinine D3 7.22 - 85.2 0.27 1.34 101.5 0.21 1.06 
6-acetylmorphine Cotinine D3 7.65 - 103.6 0.89 2.95 85.4 0.76 2.50 
Azathioprine Cotinine D3 7.75 - 109.5 0.41 1.36 83.8 0.36 1.20 
Methotrexate Amphetamine D5 7.89 - 98.8 7.11 23.45 114.1 9.04 29.83 
Caffeine Cotinine D3 8.29 - 96.6 121* 581* 131.7 1.11 5.57 
O-desmethyltramadol Cotinine D3 8.29 - 87.3 0.31 31.41 93.9 0.28 27.79 
Amphetamine Amphetamine D5 8.39 - 91.7 1.23 4.07 107.8 1.11 3.65 
Trimethoprim Methamphetamine D5 8.43 - 109.6 0.73 2.41 123.7 0.51 1.67 
Methamphetamine Methamphetamine D5 8.51 - 102.1 0.95 3.13 97.1 0.71 2.35 
MDA MDA D5 8.59 - 99.4 0.99 3.26 99.1 1.00 3.30 
MDMA MDMA D5 8.62 - 118.5 0.34 1.70 112.9 0.27 1.35 
Sulfamethoxazole Benzoylecgonine D8 9.56 - 102.8 0.72 2.38 111.0 0.47 1.56 
Benzoylecgonine Benzoylecgonine D8 9.68 - 106.3 0.21 1.07 116.4 0.18 0.91 
Mephedrone Mephedrone D3 9.79 - 94.8 0.55 2.75 103.7 0.44 2.19 
Ketamine Ketamine D4 10.59 - 111.6 0.24 1.20 115.6 0.19 0.93 
Heroin Heroin D9 10.85 - 105.3 4.18 20.89 103.0 3.44 17.21 
Tramadol Metoprolol D7 10.97 - 69.5 0.30 30.03 88.3 0.21 21.29 
Norketamine Norketamine D4 11.08 - 98.9 0.72 2.37 108.6 0.56 1.86 
Metoprolol Metoprolol D7 11.17 - 97.4 0.28 1.40 104.3 0.19 0.96 
Cocaine Cocaine D3 11.32 - 97.4 0.46 2.31 105.2 0.22 1.11 
N-desmethyltramadol Cocaine D3 11.88 - 81.3 0.56 27.90 98.8 0.30 14.97 
MDPV Cocaethylene D3 12.11 - 136.8 0.48 2.41 87.9 0.12 0.59 
Ifosfamide Metoprolol D7 12.69 - 89.2 0.31 1.53 80.2 0.24 1.22 
Cocaethylene Cocaethylene D3 12.91 - 109.9 1.31 6.54 107.4 0.21 1.04 
Carbamazepine10,11-epoxide Carbamazepine 13C6 13.47 - 143.7 0.53 1.76 126.9 0.55 1.82 
10,11-Dihydro-10-hydroxycarbamazepine Carbamazepine 13C6 13.49 - 152.2 0.99 9.94 120.6 0.84 8.41 
Mirtazapine Mirtazapine D3 13.52 - 84.7 0.39 1.94 97.0 0.25 1.25 
Azithromycin EDDP D3 13.95 - 100.1 0.74 2.45 87.5 1.35 4.45 
Venlafaxine Metoprolol D7 14.14 - 70.2 0.37 1.83 89.5 0.24 1.20 
EDDP EDDP D3 14.80 - 111.6 0.23 1.13 113.6 0.29 1.47 
Citalopram Citalopram D6 15.06 - 119.9 1.24 12.40 124.1 1.41 14.10 
Propranolol Propranolol D7 15.14 - 105.0 0.68 2.25 102.7 0.73 2.41 
Desmethylcitalopram Citalopram D6 15.17 - 93.1 0.31 1.54 110.9 0.36 1.82 
Carbamazepine Carbamazepine 13C6 16.15 - 88.3 0.27 1.37 102.5 0.19 0.93 
Diltiazem Carbamazepine 13C6 16.72 - 118.1 0.27 2.68 82.3 0.32 3.23 
Tylosin Methadone D9 17.25 - 98.3 3.27 16.34 110.0 2.23 11.14 
Methadone Methadone D9 17.59 - 109.0 0.20 1.01 111.7 0.21 1.04 
Gliclazide Quetiapine D8 17.80 - 80.1 0.22 1.09 108.4 0.16 0.82 
Quetiapine Quetiapine D8 17.87 - 72.6 0.26 1.32 95.1 0.21 1.07 
Temazepam Temazepam D5 18.16 - 107.3 0.18 0.92 113.9 0.14 0.69 
Fluoxetine Fluoxetine D5 18.35 - 110.7 0.50 2.52 111.1 1.42 7.08 
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Norfluoxetine Fluoxetine D5 18.42 - 94.8 0.42 2.12 91.7 1.27 6.35 
Cetirizine Temazepam D5 18.68 - 77.3 0.52 1.72 114.3 0.32 1.06 
Clarithromycin Methadone D9 18.87 - 80.9 0.34 1.69 97.2 0.28 1.40 
Sertraline Sertraline D3 19.22 - 91.5 0.74 3.72 105.0 1.21 6.05 
3-benzophenone Methadone D9 21.23 - 58.5 0.37 1.87 89.4 0.19 0.97 
Tamoxifen Tamoxifen 13C2 15N 22.39 - 85.2 0.70 3.50 98.4 0.76 3.82 
Enantio-selective Chirobiotic V 
S(-)-atenolol S(-)-atenolol-d7 44.3 0.5 21.4 17.4 58.0 55.1 32.7 109.1 
R(+)-atenolol R(+)-atenolol-d7 48.5  19.5 28.7 95.8 54.8 30.8 102.7 
S(+)-citalopram S(+)-citalopram-d7 57.8 0.5 91.9 0.24 13.1 82.3 0.21 11.2 
R(-)-citalopram R(-)-citalopram-d7 62.9  95.1 0.31 13.7 76.9 0.27 11.8 
S(+)-desmethylcitalopram S(+)-citalopram-d7 55.7 0.5 99.7 0.36 1.21 73.2 0.29 0.96 
R(-)-desmethylcitalopram R(-)-citalopram-d7 71.7  102.4 0.50 1.68 77.3 0.40 1.34 
S(+)-fluoxetine S(+)-fluoxetine-d5 39.8 0.5 120.4 0.07 0.22 108.7 0.04 0.14 
R(-)-fluoxetine R(-)-fluoxetine-d5 43.2  91.2 0.08 0.26 108.3 0.05 0.17 
R(-)-mirtazapine R(-)-mirtazapine-d7 18.5 0.6 72.5 0.40 1.32 105.8 0.40 1.32 
S(+)-mirtazapine S(+)-mirtazapine-d7 23.1  81.5 1.17 3.89 120.1 0.86 2.86 
S(-)-metoprolol S(-)-metoprolol-d7 28.4 0.5 87.2 0.06 0.18 87.2 0.04 0.12 
R(+)-metoprolol R(+)-metoprolol-d7 31.3  87.1 0.08 0.27 86.2 0.05 0.15 
S(-)-propranolol S(-)-propranolol-d7 31.2 0.5 109.4 0.09 0.30 108.8 0.05 0.17 
R(+)-propranolol R(+)-propranolol-d7 34.8  108.9 0.08 0.26 110.6 0.06 0.20 
Enantio-selective CBH 
R(-)-MDMA R(-)-MDMA-d5 21.9 0.5 81.0 0.3 1.4 - - - 
S(+)-MDMA S(+)-MDMA-d5 32.9  100.0 0.3 1.3 - - - 
R(-)-Amphetamine R(-)-Amphetamine-d5 15.5 0.5 76.0 0.8 2.9 - - - 




Table S3. Repeatability of sample volume collected by automated sampler using a 5 ft suction line 





















1 13.4 26 16.3 51 15.0 76 15.4 
2 13.2 27 16.8 52 14.7 77 14.0 
3 16.4 28 16.7 53 16.6 78 13.5 
4 15.9 29 14.0 54 14.5 79 13.5 
5 16.0 30 14.5 55 17.2 80 12.9 
6 16.1 31 16.6 56 16.8 81 12.6 
7 17.3 32 16.7 57 16.8 82 17.0 
8 16.8 33 17.4 58 15.2 83 16.7 
9 17.0 34 16.6 59 16.5 84 16.5 
10 16.9 35 17.8 60 16.4 85 15.9 
11 12.7 36 17.8 61 17.2 86 16.9 
12 17.2 37 17.3 62 17.3 87 16.0 
13 13.1 38 16.9 63 18.3 88 16.3 
14 17.3 39 18.3 64 16.7 89 16.4 
15 17.5 40 17.6 65 17.1 90 17.5 
16 17.3 41 17.3 66 17.2 91 16.4 
17 17.0 42 13.3 67 17.0 92 17.2 
18 18.2 43 18.0 68 15.9 93 17.6 
19 17.7 44 17.0 69 18.6 94 14.3 
20 17.2 45 17.6 70 17.3 95 17.7 
21 17.7 46 16.5 71 17.1 96 18.1 
22 15.5 47 17.5 72 18.1 97 17.7 
23 15.0 48 17.2 73 12.8 98 17.2 
24 17.6 49 17.5 74 17.5 99 16.8 




Table S4.  Measured variables during influent and effluent wastewater sampling campaigns.   
Measured variable 
Day of week 
Mon Tues Wed Thurs Fri Sat Sun Mon 
Influent wastewater (December 2014) 
Total flow - portable (m3 d-1) 32,444 36,843 34,363 42,651 38,857 40,247 38,266 36,369 
Total flow - on-site (m3 d-1) 30,408 39,954 37,327 43,683 39,564 37,391 40,963 39,068 
Difference (%) 6 -8 -9 -2 -2 7 -7 -7 
Rainfall (mm) 0.0 1.0 3.7 15.9 0.0 0.2 0.2 0.4 
Wastewater temp. (⁰C) 14.0 12.0 13.0 10.0 11.0 11.0 12.0 13.0 
Mean ambient temp. (⁰C) 2.3 8.1 6.2 7.5 2.5 2.2 7.1 5.4 
Collected wastewater temp (⁰C) 1.0 2.0 1.0 1.0 1.0 1.0 2.0 1.0 
pH 7.7 7.5 7.5 7.2 7.4 8.0 7.8 7.2 
TOC (mg L-1) 123.1 79.0 233.5 63.6 101.0 171.9 73.3 123.4 
DOC (mg L-1) 53.2 53.6 103.1 23.7 45.6 39.4 42.3 29.6 
Suspended solids (mg L-1) 392.7 295.0 395.3 329.7 302.7 348.0 294.3 282.0 
Effluent wastewater (January 2015) 
Total flow - portable (m3 d-1) 40,227 40,655 42,354 42,185 41,242 38,942 37,496 35,087 
Rainfall (mm) 0.0 2.8 4.3 0.2 1.0 0.0 0.2 0.2 
Wastewater temp. (⁰C) 8.0 9.0 9.0 8.0 8.0 9.0 8.0 8.0 
Mean ambient temp. (⁰C) 0.6 3.2 3.9 0.3 5.2 2.7 7.9 5.1 
Collected wastewater temp. (⁰C) 1.0 1.0 1.0 -1.0 1.0 1.0 2.0 1.0 
pH 7.2 7.2 7.7 7.7 7.0 6.9 6.9 6.8 
TOC (mg L-1) 24.0 13.1 9.7 13.1 34.5 10.1 11.2 55.2 
DOC (mg L-1) 10.1 8.8 7.3 8.2 27.6 8.5 8.7 39.0 
Suspended solids (mg L-1) 92.2 45.6 41.4 42.0 71.6 54.6 52.4 66.4 
Key: TOC, total organic carbon; DOC, dissolved organic carbon 





Table S5.  Loss of micropollutants in water stored in polypropylene bottles at 18 ⁰C and 4 ⁰C over a 
24 h time period (n=2). Underlined values show those out with ±20 % significance level 
Micropollutant class Micropollutant 
Concentration relative to t=0 after 
24 h storage (%) 
18 ⁰C 4 ⁰C 
UV filters Benzophenone-1 111.4 108.6 
 Benzophenone-2 114.4 106.4 
 Benzophenone-3 98.2 94.7 
 Benzophenone-4 105.2 110.7 
Parabens Methylparaben 92.3 98.0 
 Ethylparaben 87.1 98.7 
 Propylparaben 89.4 106.4 
 Butylparaben 105.8 103.8 
Plasticizer Bisphenol-A 90.0 95.1 
Steroid estrogens E1 98.3 102.0 
 E2 102.4 90.7 
 EE2 104.5 93.0 
Antibacterials/antibiotics Sulfasalazine 99.6 89.3 
 Clarithromycin 105.3 82.8 
 Azithromycin 89.9 87.4 
 Trimethoprim 112.4 105.4 
 Sulfamethoxazole 102.3 101.1 
 Triclosan 94.0 91.0 
Hypertension Valsartan 113.3 105.4 
 Irbesartan 117.7 114.9 
 Lisinopril 108.8 103.0 
NSAIDs Ketoprofen 97.8 97.2 
 Ibuprofen 96.5 99.7 
 Naproxen 100.2 98.0 
 Diclofenac 114.7 92.1 
 Acetaminophen 94.5 99.7 
Lipid regulators Bezafibrate 96.6 100.8 
 Atorvastatin 110.5 99.8 
Antihistamines Fexofenadine 110.9 85.0 
 Cetirizine 109.1 115.8 
Diabetes Metformin 101.0 100.4 
 Gliclazide 98.7 101.4 
Cough suppressant Pholcodine 111.4 100.3 
Beta-blocker Atenolol 99.6 98.3 
 Metoprolol 97.4 99.2 
 Propranolol 102.3 98.5 
H2 receptor agonists Ranitidine 111.2 102.6 
 Cimetidine 90.2 92.1 
X-ray contrast media Iopromide 98.7 100.1 
Drug precursor and metabolite Ephedrine/pseudoephedrine 108.5 91.0 
 Norephedrine 108.5 103.4 
Anti-cancer Azathioprine 97.6 97.9 
 Methotrexate 109.2 98.8 
 Ifosfamide 107.4 95.3 
 Tamoxifen 30.8 34.3 
Anaesthetic and metabolite Ketamine 96.9 99.8 
 Norketamine 95.8 98.1 
Anti-depressants and metabolites Venlafaxine 102.9 102.0 
 Desvenlafaxine 102.9 101.0 
 Fluoxetine 104.2 101.8 
 Norfluoxetine 86.8 101.0 
 Sertraline 85.8 93.5 
 Mirtazapine 95.1 98.9 
 Citalopram 102.9 95.3 
 Desmethylcitalopram 82.5 104.4 
Anti-epileptic and metabolites Carbamazepine 96.7 99.5 
 Carbamazepine10,11-epoxide 99.9 98.6 
 10,11-Dihydro-10-hydroxycarbamazepine 96.3 97.4 
Calcium channel blocker Diltiazem 111.8 106.4 
Hypnotic Temazepam 101.5 107.0 
Anti-psychotic Quetiapine 95.6 92.3 
Veterinary Tylosin 96.6 104.1 
Human indicators and metabolites Creatinine 93.7 110.1 
 Nicotine 84.1 98.5 
 Caffeine 98.1 98.0 
 Cotinine 96.8 98.2 
 1,7 dimethylxantine 107.4 105.0 
Analgaesics and metabolites Morphine 90.3 93.1 
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 Dihydromorphine 94.3 94.8 
 Normorphine 92.4 100.9 
 Methadone 95.3 106.8 
 EDDP 92.1 94.9 
 Codeine 96.9 99.3 
 Norcodeine 91.2 103.2 
 Dihydrocodeine 90.8 96.2 
 Tramadol 99.7 97.6 
 N-desmethyltramadol 84.6 100.1 
 O-desmethyltramadol 97.2 101.4 
Stimulants and metabolites Amphetamine 100.3 101.7 
 Methamphetamine 92.9 99.5 
 MDMA 94.1 96.1 
 MDA 100.3 104.8 
 Cocaine 91.3 102.7 
 Benzoylecgonine 110.1 97.6 
 Anhydroecgonine methylester 86.9 102.1 
 Cocaethylene 97.2 102.4 
 Mephedrone 103.2 93.5 
 MDPV 95.4 102.7 
Opioid and metabolite Heroin 88.6 98.8 




Table S6. Stability (%) of micropollutants in collected influent and effluent wastewater stored at 18 ⁰C and 
4 ⁰C over a 24 h time period (n=2). Underlined values show those out with ±20 % significance level 
Micropollutant 
class Micropollutant 









18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 
UV filters Benzophenone-1 98.9 88.8 112.6 91.5 97.7 85.6 90.9 97.9 
 Benzophenone-2 97.2 88.3 87.0 99.4 115.5 103.9 80.8 95.3 
 Benzophenone-3 47.7 57.8 60.7 65.1 69.5 64.8 63.8 78.2 
 Benzophenone-4 105.3 100.3 102.9 104.0 116.5 106.3 100.4 102.0 
Parabens Methylparaben 55.0 91.6 31.9 65.2 72.3 89.5 21.1 47.9 
 Ethylparaben 66.7 87.0 51.7 80.1 85.7 94.1 38.0 65.2 
 Propylparaben 71.3 91.0 72.3 88.3 46.9 91.8 54.1 75.4 
 Butylparaben 50.7 81.4 59.1 80.2 31.1 81.5 57.5 93.4 
Plasticizer Bisphenol-A 124.3 96.5 98.3 106.3 102.5 102.5 71.3 116.4 
Steroid estrogens E1 88.1 107.6 65.8 101.4 120.7 81.5 57.5 93.4 
 E2 45.7 89.9 39.3 85.5 58.1 92.2 1.1 34.9 
 EE2 113.1 106.8 92.1 106.1 86.5 85.7 104.0 110.4 
Antibacterials/ 
antibiotics Sulfasalazine 93.7 85.9 98.3 96.0 95.4 95.0 98.4 90.8 
 Clarithromycin 100.6 88.1 108.3 85.6 86.6 85.4 86.4 100.0 
 Azithromycin 81.6 93.2 100.1 85.2 67.6 82.5 101.4 89.0 
 Trimethoprim 92.6 82.6 84.1 81.4 94.9 88.0 96.8 101.7 
 Sulfamethoxazole 96.4 91.6 92.1 88.4 106.4 93.2 93.1 93.1 
 Triclosan - - - - - - - - 
Hypertension Valsartan 92.0 95.0 109.0 106.5 121.2 111.4 99.5 98.6 
 Irbesartan 91.5 90.2 97.1 96.1 92.9 107.4 93.2 88.7 
 Lisinopril 114.1 81.9 105.5 83.6 89.1 81.5 76.3 101.1 
NSAIDs Ketoprofen 102.0 97.5 102.2 105.9 98.7 107.6 95.7 91.7 
 Ibuprofen 97.5 89.1 100.2 102.3 99.2 100.3 83.2 83.2 
 Naproxen 96.4 99.1 98.6 100.3 103.5 94.9 100.3 95.4 
 Diclofenac 113.0 103.9 108.2 102.7 101.9 107.6 95.3 88.7 
 Acetaminophen 74.1 96.5 7.3 14.5 98.0 97.3 2.0 20.4 
Lipid regulators Bezafibrate 91.4 91.9 95.8 103.5 91.8 87.0 98.4 100.9 
 Atorvostatin 90.3 87.5 79.0 84.1 113.6 112.8 101.7 89.4 
Antihistamines Fexofenadine 99.4 106.6 94.0 103.9 125.5 102.1 95.3 101.0 
 Cetirizine 253.0 131.8 259.2 137.5 188.7 111.0 213.5 118.0 
Diabetes Metformin 98.6 98.0 96.7 99.7 94.1 98.7 103.4 97.7 
 Gliclazide 102.3 102.1 83.7 97.8 103.1 98.7 80.9 84.5 
Cough suppressant Pholcodine 119.6 101.6 106.4 102.1 96.7 99.7 95.2 86.4 
Beta-blocker Atenolol 95.6 92.4 100.3 93.2 94.0 89.0 102.2 99.1 
 Metoprolol 96.0 94.1 96.7 96.2 96.4 92.5 101.7 92.3 
 Propranolol 102.8 96.0 93.1 93.6 100.0 95.7 100.3 98.9 
H2 receptor agonists Ranitidine 90.1 89.2 97.7 86.1 92.7 94.9 91.5 94.8 
 Cimetidine 93.2 89.5 74.5 81.5 100.0 92.0 108.0 91.4 
X-ray contrast 
media Iopromide 100.0 89.5 92.8 93.6 95.5 92.8 91.0 90.2 
Drug precursor and 
metabolite Ephedrine/pseudoephedrine 75.9 77.6 95.0 90.0 133.2 116.2 119.7 102.1 
 Norephedrine 93.4 84.9 95.9 85.6 96.4 101.5 134.6 91.6 
Anti-cancer Azathioprine 98.3 90.3 95.3 93.2 91.5 88.7 93.7 90.3 
 Methotrexate - - - - - - - - 
 Ifosfamide 94.3 91.0 98.1 99.5 99.7 92.4 107.4 99.1 
 Tamoxifen - - - - - - - - 
Anaesthetic and 
metabolite Ketamine 104.1 100.2 103.7 102.2 101.8 93.2 105.4 97.7 
 Norketamine 103.2 100.5 102.4 96.8 103.3 99.5 104.6 96.8 
Anti-depressants 
and metabolites Venlafaxine 105.2 104.6 100.1 85.2 93.8 96.2 102.0 98.3 
 Fluoxetine 95.0 81.7 75.7 57.3 96.5 80.5 88.3 87.8 
 Norfluoxetine 74.6 71.3 60.0 58.8 95.8 80.7 96.0 83.2 
 Sertraline 62.7 81.8 81.5 84.6 111.9 119.4 82.6 87.4 
 Mirtazapine 101.8 102.3 95.6 93.2 98.8 92.5 107.2 101.3 
 Citalopram 106.8 98.2 110.8 90.2 92.3 91.6 106.2 108.1 




metabolites Carbamazepine 95.9 91.6 96.2 96.0 101.3 94.1 98.2 92.2 
 Carbamazepine10,11-epoxide 94.9 88.1 101.1 97.3 95.7 87.5 97.3 89.6 
 10,11-Dihydro-10-hydroxycarbamazepine 94.0 91.3 95.8 93.3 97.4 86.7 101.1 92.6 
Calcium channel 
blocker Diltiazem <10.0 84.7 73.9 81.1 109.0 92.2 162.9 119.9 
Hypnotic Temazepam 105.7 97.3 103.8 93.7 97.6 96.0 112.3 100.5 
Anti-psychotic Quetiapine 99.0 95.7 99.2 97.7 93.4 92.4 100.6 100.0 
Veterinary Tylosin 98.3 98.6 91.5 84.4 106.2 89.7 104.0 105.0 
Human indicators 
and metabolites Creatinine 5.7 80.0 45.8 112.0 43.2 89.0 102.4 104.8 
 Nicotine 113.7 94.8 113.6 111.0 115.8 111.8 82.1 91.6 
 Caffeine 97.0 97.2 84.1 87.0 99.8 92.6 78.2 86.8 
 Cotinine 96.1 94.2 96.0 94.4 100.6 93.9 90.7 96.3 
 1,7 dimethylxantine 95.8 92.1 87.4 89.0 101.4 96.6 143.7 94.3 
Analgaesics and 
metabolites Morphine 126.3 114.3 142.4 113.3 175.0 117.6 138.9 108.4 
 Dihydromorphine 64.7 95.8 69.0 100.8 118.3 103.1 92.4 91.3 
 Normorphine 74.7 93.0 87.9 95.2 124.7 106.8 118.6 104.1 
 Methadone 98.4 102.8 92.9 92.5 97.6 93.4 108.4 105.9 
 EDDP 98.2 100.9 98.3 98.0 101.7 97.4 103.7 95.5 
 Codeine 116.0 98.3 97.9 97.6 118.4 99.4 99.5 92.5 
 Norcodeine 107.1 91.6 105.0 92.2 93.4 87.5 100.3 97.0 
 Dihydrocodeine 89.7 87.1 89.0 91.1 99.4 90.4 99.8 99.1 
 Tramadol 103.9 98.7 108.1 102.7 94.7 90.6 101.5 92.4 
 N-desmethyltramadol 164.4 105.5 111.3 80.6 80.1 87.5 98.5 99.4 
 O-desmethyltramadol 95.2 90.9 99.0 90.8 100.0 90.5 97.2 97.5 
Stimulants and 
metabolites Amphetamine 97.2 97.4 75.6 93.6 86.0 89.2 82.1 93.4 
 Methamphetamine 96.7 97.4 93.8 97.5 104.5 101.9 102.7 98.6 
 MDMA 108.6 102.1 97.8 93.0 105.0 95.3 99.5 98.1 
 MDA 97.5 94.1 93.0 98.5 105.4 95.5 110.5 101.5 
 Cocaine 75.2 94.3 68.8 94.0 65.5 85.6 62.5 90.8 
 Benzoylecgonine 130.3 102.2 127.8 101.8 11.6 93.5 132.9 100.6 
 Anhydroecgonine methylester 121.9 100.0 122.0 119.5 109.9 109.6 88.5 86.7 
 Cocaethylene 95.5 95.2 87.0 98.8 79.2 87.0 83.7 99.4 
 Mephedrone 90.2 95.8 80.2 108.8 73.3 89.1 79.2 91.8 
 MDPV 156.9 103.0 107.3 92.7 72.5 89.4 110.3 104.8 
Opioid and 
metabolite Heroin 2.3 84.1 59.3 81.2 20.2 56.1 32.3 84.1 
 6-acetylmorphine 62.4 93.6 126.9 105.3 99.5 89.6 101.7 96.9 
Key: E1, estrone; E2, 17β-estradiol; EE2, 17α-ethinylestradiol; EDDP, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-
amphetamine; MDPV, methylenedioxypyrovalerone; -, the initial concentration was below the method 
quantitation limit for 10 mL extractions (triclosan, <81 ng L-1; methotrexate, <117 ng L-1; tamoxifen, 




Table S7. Stability (%) of micropollutants in collected influent and effluent wastewater stored with the 
addition of NaN3 (1 g L-1) at 18 ⁰C and 4 ⁰C over a 24 hour time period (n=2). Underlined values show 
those out with ±20 % significance level 
Micropollutant 
class Micropollutant 









18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 
UV filters Benzophenone-1 118.7 120.9 142.5 123.3 118.7 119.9 107.7 109.9 
 Benzophenone-2 120.6 118.9 103.4 90.4 123.2 111.0 39.9 69.9 
 Benzophenone-3 70.8 70.6 72.3 81.0 107.8 100.6 100.8 121.8 
 Benzophenone-4 101.2 97.6 97.8 101.2 95.9 95.0 97.8 101.7 
Parabens Methylparaben 92.6 92.9 62.6 90.2 88.8 92.1 48.2 75.5 
 Ethylparaben 93.9 94.1 82.1 90.4 104.2 122.2 71.8 93.7 
 Propylparaben 86.8 100.1 94.1 88.1 87.6 87.1 79.2 95.3 
 Butylparaben 84.4 100.6 87.9 100.4 93.0 95.2 118.2 131.3 
Plasticizer Bisphenol-A 119.4 95.6 97.5 82.0 108.6 100.7 120.4 90.6 
Steroid estrogens E1 119.2 113.3 115.3 106.8 136.2 111.7 157.8 142.9 
 E2 87.9 86.1 84.6 89.1 52.9 64.2 6.2 35.2 
 EE2 118.9 114.6 127.6 104.2 96.8 98.4 112.4 119.9 
Antibacterials/ 
antibiotics Sulfasalazine 124.6 117.8 148.6 132.9 118.7 97.7 123.8 111.4 
 Clarithromycin 108.5 111.9 107.8 91.0 146.7 111.8 129.3 129.3 
 Azithromycin 129.1 115.2 115.7 103.3 137.7 148.5 180.0 255.5 
 Trimethoprim 172.8 114.8 171.2 146.3 255.0 288.4 206.8 215.2 
 Sulfamethoxazole 110.4 104.2 106.1 89.5 127.7 106.6 111.5 105.2 
 Triclosan - - - - - - - - 
Hypertension Valsartan 106.9 100.0 95.3 91.9 109.2 95.7 97.0 91.5 
 Irbesartan 101.0 89.7 93.7 81.5 108.3 96.3 79.1 77.0 
 Lisinopril 222.4 149.2 229.9 166.5 230.7 284.6 127.0 142.4 
NSAIDs Ketoprofen 98.5 99.5 104.3 100.5 111.1 84.0 99.3 93.1 
 Ibuprofen 101.7 95.0 112.9 97.2 104.3 100.0 108.6 95.2 
 Naproxen 100.1 94.0 93.2 85.6 106.4 105.3 104.5 102.2 
 Diclofenac 104.4 113.7 97.9 85.6 113.8 96.4 81.8 90.8 
 Acetaminophen 96.4 96.1 52.2 59.4 103.3 95.8 62.1 83.1 
Lipid regulators Bezafibrate 101.7 91.6 110.0 102.9 98.7 95.6 104.9 103.5 
 Atorvostatin 122.2 132.4 114.8 97.0 145.9 113.2 114.8 86.1 
Antihistamines Fexofenadine 99.7 116.3 93.7 81.5 105.9 112.5 97.5 95.0 
 Cetirizine 242.0 178.8 242.5 157.8 241.0 179.3 121.6 91.2 
Diabetes Metformin 96.4 99.0 97.0 94.7 103.2 98.3 101.4 92.9 
 Gliclazide 93.4 84.4 90.0 67.8 106.6 99.3 75.1 51.5 
Cough suppressant Pholcodine 89.9 69.9 83.3 65.4 56.1 45.8 63.0 55.4 
Beta-blocker Atenolol 94.6 91.4 104.9 93.8 109.9 98.5 106.0 103.1 
 Metoprolol 96.9 95.2 106.0 94.8 105.0 97.2 97.7 98.3 
 Propranolol 96.9 92.6 105.0 102.7 101.9 92.0 103.8 99.2 
H2 receptor agonists Ranitidine 92.4 95.8 112.6 98.5 113.1 99.9 90.2 90.8 
 Cimetidine 106.5 91.4 103.2 80.9 112.0 102.2 94.2 71.0 
X-ray contrast 
media Iopromide 98.6 90.9 103.3 94.7 93.9 96.6 93.8 95.8 
Drug precursor and 
metabolite Ephedrine/pseudoephedrine 82.9 74.7 95.0 77.5 180.2 98.8 99.3 113.4 
 Norephedrine 76.7 61.0 81.2 72.0 73.1 72.4 101.9 112.2 
Anti-cancer Azathioprine 93.3 85.0 93.5 77.4 99.7 90.4 81.1 83.2 
 Methotrexate - - - - - - - - 
 Ifosfamide 88.1 86.9 101.2 90.6 109.2 98.9 141.3 132.6 
 Tamoxifen - - - - - - - - 
Anaesthetic and 
metabolite Ketamine 98.9 95.9 108.1 98.3 105.3 90.0 101.8 95.9 
 Norketamine 98.5 97.3 105.8 91.8 99.2 91.3 105.5 104.3 
Anti-depressants 
and metabolites Venlafaxine 100.6 100.6 109.1 101.9 115.2 98.1 111.6 103.2 
 Desmethylvenlafaxine 97.7 93.3 105.5 96.7 114.6 98.8 105.5 100.0 
 Fluoxetine 94.4 68.9 78.6 55.8 96.5 74.0 104.7 83.1 
 Norfluoxetine 80.3 65.6 61.2 54.1 95.8 71.4 121.6 91.2 
 Sertraline 88.2 55.5 86.2 63.1 80.6 64.2 84.7 84.7 
 Mirtazapine 98.5 94.2 99.3 93.7 99.0 95.6 104.1 99.0 
 Citalopram 100.7 100.0 103.5 90.8 115.4 91.8 109.4 103.5 
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 Desmethylcitalopram 54.5 34.0 84.8 78.7 62.3 44.2 49.8 60.1 
Anti-epileptic and 
metabolites Carbamazepine 94.6 91.6 104.4 96.4 102.2 93.4 98.8 94.7 
 Carbamazepine10,11-epoxide 87.5 88.1 102.7 92.3 92.8 84.6 90.5 82.7 
 10,11-Dihydro-10-hydroxycarbamazepine 88.3 85.7 104.7 91.9 102.8 90.2 97.7 93.0 
Calcium channel 
blocker Diltiazem <1.0 <1.0 58.6 34.2 <1.0 <1.0 <1.0 <1.0 
Hypnotic Temazepam 102.1 93.4 106.3 94.8 110.0 93.8 112.8 108.5 
Anti-psychotic Quetiapine 95.9 91.9 100.8 91.8 115.7 98.3 102.8 99.4 
Veterinary Tylosin 96.8 108.4 104.0 85.4 130.9 106.7 135.6 121.8 
Human indicators 
and metabolites Creatinine 32.1 34.0 <1 43.8 36.7 38.0 102.4 100.0 
 Nicotine 100.4 145.9 139.3 123.0 114.0 78.2 114.3 99.2 
 Caffeine 100.4 95.5 95.0 88.4 102.1 91.4 101.9 110.2 
 Cotinine 94.0 92.6 106.4 92.5 103.9 93.8 101.9 105.3 
 1,7 dimethylxantine 96.2 89.8 94.8 85.8 107.8 97.3 103.2 104.9 
Analgaesics and 
metabolites Morphine 84.3 90.0 93.7 98.9 120.1 101.6 110.0 84.1 
 Dihydromorphine 77.7 66.1 127.0 107.3 73.8 67.5 56.1 38.4 
 Normorphine 91.4 74.3 118.3 100.7 62.2 52.1 74.0 91.1 
 Methadone 95.9 86.6 102.7 90.6 122.1 99.0 113.0 101.3 
 EDDP 103.3 100.0 109.4 100.9 108.5 96.3 112.7 102.3 
 Codeine 110.6 99.2 109.1 99.1 112.4 107.9 101.3 99.2 
 Norcodeine 94.9 98.0 115.6 107.3 81.6 71.9 92.7 102.7 
 Dihydrocodeine 94.7 90.6 102.2 92.1 94.3 88.4 104.0 105.6 
 Tramadol 97.8 101.3 112.9 103.2 107.0 92.5 95.2 91.7 
 N-desmethyltramadol 199.8 193.5 119.7 116.3 194.5 166.9 146.3 136.2 
 O-desmethyltramadol 95.9 90.9 98.8 87.2 106.4 92.1 97.0 95.4 
Stimulants and 
metabolites Amphetamine 116.1 106.5 114.9 112.3 182.0 182.1 117.9 119.0 
 Methamphetamine 92.5 88.2 94.4 94.1 96.3 81.7 89.2 90.8 
 MDMA 111.6 105.0 108.3 94.9 112.7 104.4 101.9 98.7 
 MDA 90.0 91.2 99.6 100.0 106.6 98.5 108.7 100.9 
 Cocaine 84.2 99.1 84.9 89.9 69.2 94.1 73.4 96.2 
 Benzoylecgonine 126.8 109.7 126.6 102.0 140.3 106.4 141.6 111.9 
 Anhydroecgonine methylester 96.1 129.0 124.4 115.2 91.8 70.2 85.8 80.5 
 Cocaethylene 93.8 99.4 97.7 98.3 89.6 93.2 100.0 105.2 
 Mephedrone 84.3 97.3 93.2 96.0 78.1 96.4 90.9 100.0 
 MDPV 180.7 184.0 118.2 122.9 177.1 157.7 155.9 112.2 
Opioid and 
metabolite Heroin <1.0 <1.0 23.3 47.1 <1.0 <1.0 <1.0 <1.0 
 6-acetylmorphine 34.8 20.5 138.5 101.7 2.5 4.0 4.0 15.0 
Key: E1, estrone; E2, 17β-estradiol; EE2, 17α-ethinylestradiol; EDDP, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-
amphetamine; MDPV, methylenedioxypyrovalerone; -, the initial concentration was below the method 
quantitation limit for 10 mL extractions (triclosan, <81 ng L-1; methotrexate, <117 ng L-1; tamoxifen, 






Table S8. Stability (%) of micropollutants in collected influent and effluent wastewater stored at pH 2 at 18 













18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 18 ⁰C 4 ⁰C 
UV filters Benzophenone-1 83.4 102.2 74.8 118.4 85.6 85.3 66.0 61.1 
 Benzophenone-2 58.9 73.3 52.0 67.8 87.1 96.1 77.2 63.7 
 Benzophenone-3 40.9 43.5 43.6 50.2 62.3 69.8 58.4 59.9 
 Benzophenone-4 104.3 125.0 120.0 106.9 115.6 112.9 106.6 102.2 
Parabens Methylparaben 100.0 99.6 119.8 109.2 105.9 97.6 98.7 96.4 
 Ethylparaben 98.9 112.0 112.2 113.3 90.6 81.0 93.5 93.2 
 Propylparaben 84.8 85.2 109.2 90.4 89.0 80.8 89.5 80.9 
 Butylparaben 93.6 96.8 100.9 100.6 110.2 97.4 109.4 102.0 
Plasticizer Bisphenol-A 189.8 186.1 162.3 171.1 99.1 94.3 127.9 134.2 
Steroid estrogens E1 90.8 94.6 106.0 97.3 94.4 87.8 102.8 94.4 
 E2 88.4 92.2 101.2 90.2 96.2 87.0 89.3 96.6 
 EE2 95.6 117.0 94.4 103.7 106.8 97.6 117.9 111.9 
Antibacterials/ 
antibiotics Sulfasalazine 82.7 80.6 93.6 82.1 99.1 87.7 80.0 77.3 
 Clarithromycin 23.9 56.7 59.4 78.7 34.3 73.0 47.4 74.2 
 Azithromycin 27.6 41.5 34.0 40.7 60.0 70.1 44.7 59.6 
 Trimethoprim 13.1 13.2 19.3 16.7 69.7 57.1 23.5 22.4 
 Sulfamethoxazole <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 <1.0 2.9 
 Triclosan - - - - - - - - 
Hypertension Valsartan 81.2 84.6 72.9 62.5 135.6 128.5 90.6 87.1 
 Irbesartan 95.1 103.9 66.9 88.6 78.3 64.7 75.9 50.3 
 Lisinopril 49.2 46.3 62.1 60.4 74.8 79.1 48.9 48.5 
NSAIDs Ketoprofen 90.4 88.4 95.4 97.8 89.5 98.9 90.3 92.0 
 Ibuprofen 98.3 104.4 94.5 107.8 99.2 97.1 111.7 105.4 
 Naproxen 98.6 101.7 98.6 91.9 97.6 92.2 103.5 100.2 
 Diclofenac 49.7 52.0 50.2 45.3 49.8 52.0 86.7 75.1 
 Acetaminophen 92.5 94.4 73.7 71.2 92.7 92.1 184.5 111.4 
Lipid regulators Bezafibrate 95.6 92.4 105.6 101.0 95.6 95.2 105.8 94.4 
 Atorvostatin 57.4 40.1 49.9 32.1 69.5 62.8 67.4 69.4 
Antihistamines Fexofenadine 53.2 71.7 32.1 50.4 93.8 88.4 93.0 88.5 
 Cetirizine 75.1 77.0 89.0 78.6 72.8 62.9 79.3 67.3 
Diabetes Metformin 100.8 84.3 99.7 91.1 97.3 105.2 97.2 96.0 
 Gliclazide 29.5 81.7 26.5 88.0 17.4 34.0 74.2 71.5 
Cough suppressant Pholcodine 79.6 84.1 79.5 74.1 102.2 85.3 74.0 64.9 
Beta-blocker Atenolol 94.5 91.0 98.5 101.8 103.2 92.9 97.8 95.8 
 Metoprolol 95.2 94.4 105.2 100.5 99.4 93.6 100.6 96.3 
 Propranolol 97.5 100.6 105.8 104.0 103.4 96.0 108.4 103.8 
H2 receptor agonists Ranitidine 1.8 7.5 7.6 11.7 1.3 1.2 60.2 54.0 
 Cimetidine 93.5 101.6 94.4 109.7 138.8 115.9 118.5 102.8 
X-ray contrast 
media Iopromide 95.7 92.3 101.7 100.0 99.5 94.4 97.5 91.0 
Drug precursor and 
metabolite Ephedrine/pseudoephedrine 183.5 245.3 199.5 356.5 155.7 161.3 214.8 203.5 
 Norephedrine 81.1 89.4 102.4 103.4 130.5 136.7 95.8 83.7 
Anti-cancer Azathioprine 107.7 102.7 104.3 98.9 107.4 98.4 104.6 84.0 
 Methotrexate - - - - - - - - 
 Ifosfamide 49.9 67.5 79.9 79.1 58.8 78.3 69.1 83.5 
 Tamoxifen - - - - - - - - 
Anaesthetic and 
metabolite Ketamine 92.5 100.0 103.2 101.0 100.8 92.7 102.8 99.5 
 Norketamine 95.3 95.5 101.1 99.7 98.1 95.9 103.2 102.0 
Anti-depressants 
and metabolites Venlafaxine 111.2 112.1 118.4 113.5 101.1 102.4 111.6 107.8 
 Desmethylvenlafaxine 87.2 87.0 91.3 92.3 93.1 89.3 97.7 97.7 
 Fluoxetine 82.8 91.1 80.6 83.0 83.0 98.0 93.4 100.5 
 Norfluoxetine 98.4 107.4 82.9 80.0 103.4 120.2 97.6 115.2 
 Sertraline 90.9 91.8 108.5 110.0 69.4 90.3 93.2 97.9 
 Mirtazapine 93.5 99.7 99.5 103.0 97.1 95.4 111.8 108.2 
 Citalopram 94.6 107.9 103.5 105.1 100.2 105.2 115.9 104.3 
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 Desmethylcitalopram 120.6 127.8 119.7 117.2 153.8 161.8 152.3 131.3 
Anti-epileptic and 
metabolites Carbamazepine 91.2 93.2 100.0 98.7 100.0 96.9 102.0 94.9 
 Carbamazepine10,11-epoxide <1.0 6.8 <1.0 32.2 <1.0 4.3 <1.0 39.5 
 10,11-Dihydro-10-hydroxycarbamazepine 82.8 87.4 97.2 92.6 101.5 91.0 102.3 93.9 
Calcium channel 
blocker Diltiazem 225.9 252.9 153.2 148.6 153.0 173.5 531.4 480.0 
Hypnotic Temazepam 69.5 86.7 91.0 91.6 77.9 85.7 94.7 96.0 
Anti-psychotic Quetiapine 88.4 91.4 96.2 94.1 102.7 90.2 105.5 97.5 
Veterinary Tylosin 17.4 48.1 50.8 67.5 24.7 59.4 55.1 96.4 
Human indicators 
and metabolites Creatinine 135.8 111.1 112.0 101.3 81.6 89.9 152.4 140.5 
 Nicotine 387.4 378.5 292.1 268.1 203.2 180.8 217.1 199.2 
 Caffeine 98.3 93.5 96.9 93.2 102.0 90.4 130.3 107.7 
 Cotinine 100.3 95.4 100.6 98.3 100.4 93.6 107.2 102.7 
 1,7 dimethylxantine 103.0 98.7 103.6 99.3 103.9 99.2 183.4 110.9 
Analgaesics and 
metabolites Morphine 84.3 90.0 93.7 98.9 82.5 88.2 109.2 107.2 
 Dihydromorphine 109.2 116.3 95.8 98.3 111.0 100.0 120.9 102.0 
 Normorphine 99.2 112.1 89.3 105.9 91.4 92.9 123.8 130.1 
 Methadone 93.1 106.5 109.8 111.8 104.5 116.2 124.3 117.2 
 EDDP 98.2 103.3 110.0 106.9 107.4 103.4 108.5 103.7 
 Codeine 95.4 98.6 103.6 97.0 93.0 90.4 105.4 102.9 
 Norcodeine 91.6 86.5 108.7 107.8 92.3 91.8 97.0 109.0 
 Dihydrocodeine 83.9 98.4 99.8 94.7 91.6 93.7 100.7 107.0 
 Tramadol 100.2 106.1 110.7 107.5 95.7 94.6 100.9 95.5 
 N-desmethyltramadol 101.8 110.2 133.3 118.9 79.8 76.1 113.9 109.2 
 O-desmethyltramadol 100.5 95.7 102.6 102.0 92.9 87.9 104.0 100.9 
Stimulants and 
metabolites Amphetamine 87.6 91.5 104.9 100.5 88.9 89.7 102.5 102.7 
 Methamphetamine 110.8 115.4 116.0 115.1 112.7 105.6 131.5 120.0 
 MDMA 107.4 108.0 106.1 107.0 106.4 97.5 105.3 96.3 
 MDA 102.5 104.2 107.3 105.1 115.1 114.8 112.0 106.6 
 Cocaine 93.2 98.6 104.3 98.2 96.7 95.2 104.6 97.3 
 Benzoylecgonine 88.3 89.2 92.9 90.9 86.2 83.2 90.5 88.7 
 Anhydroecgonine methylester 306.5 303.9 278.7 275.6 147.4 137.1 162.8 157.1 
 Cocaethylene 94.1 94.6 109.6 107.2 95.1 95.3 110.5 107.7 
 Mephedrone 100.3 99.4 106.5 103.1 99.2 97.5 108.2 100.9 
 MDPV 103.7 108.6 129.8 124.7 83.8 88.1 113.5 107.4 
Opioid and 
metabolite Heroin 98.3 104.8 107.4 103.7 97.0 99.1 99.0 94.4 
 6-acetylmorphine 78.7 78.1 77.6 79.2 62.0 48.4 64.9 56.9 
Key: E1, estrone; E2, 17β-estradiol; EE2, 17α-ethinylestradiol; EDDP, 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine; MDMA, 3,4-methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-
amphetamine; MDPV, methylenedioxypyrovalerone; -, the initial concentration was below the method 
quantitation limit for 10 mL extractions (triclosan, <81 ng L-1; methotrexate, <117 ng L-1; tamoxifen, 





Table S9.  Difference in micropollutant concentration (%) of influent and effluent wastewater daily composites collected in a time paced versus a volume paced manner 
(n=3). Underlined values show those out with ±20 % significance level 
Micropollutant 
class Micropollutant 
Influent wastewater (December 2014) Effluent wastewater (January 2015) 
Mon Tues Wed Thurs Fri Sat Sun Mon Mon Tues Wed Thurs Fri Sat Sun Mon 
UV filters Benzophenone-1 +12.4 0.0 NA +1.4 +27.3 +16.0 +15.6 -2.1 - - - - - - - - 
 Benzophenone-2 - - NA - - - - - - - - - - - - - 
 Benzophenone-3 +3.4 +7.6 NA +3.8 +0.7 -11.5 -7.0 -8.5 -9.4 -2.9 -19.3 -14.8 -12.7 0.0 -11.2 -17.7 
 Benzophenone-4 -4.9 -3.9 NA -5.6 -9.1 -0.6 +2.0 +4.5 +5.5 +0.4 +4.5 -6.6 +1.8 -0.3 -10.7 +6.6 
Parabens Methylparaben +3.5 +11.1 NA +5.7 +8.3 +38.0 +7.9 +15.5 +13.6 +18.2 +12.5 +16.2 +13.9 +13.1 -2.0 +2.3 
 Ethylparaben +22.0 +31.4 NA +38.3 +29.6 +70.1 +33.9 +36.7 +6.7 +12.5 +15.4 +5.0 +15.8 +9.5 -5.6 +15.4 
 Propylparaben +22.3 +25.9 NA +17.5 +20.2 +43.5 +19.5 +20.9 +4.0 -2.9 -10.7 -16.7 +1.9 +13.3 -16.7 +12.5 
 Butylparaben +21.4 +52.5 NA +18.5 +51.1 +61.0 +31.4 +38.0 - - - - - - - - 
Plasticizer Bisphenol-A -5.7 -8.2 NA -3.8 -15.1 -17.1 -6.4 -5.9 +3.9 +7.8 +8.4 -4.8 +8.4 -18.9 +13.6 +11.1 
Steroid estrogens E1 -7.5 -0.7 NA -14.2 -9.2 -14.9 -25.7 -8.7 -7.6 +7.5 +4.5 -13.7 +2.5 -3.9 -14.6 +1.3 
 E2 - - NA - - - - - - - - - - - - - 
 EE2 - - NA - - - - - - - - - - - - - 
Antibacterials/ 
antibiotics Sulfasalazine -3.5 +2.1 NA -0.1 +7.7 +6.0 -8.0 +20.5 +8.7 +7.3 +14.9 +7.3 +5.7 +5.5 +2.3 +19.0 
 Clarithromycin +7.2 -5.2 NA +13.9 +2.2 -16.2 -19.8 -6.5 -5.5 -5.4 -4.2 -0.5 -0.1 -0.6 -6.9 +0.5 
 Azithromycin +13.3 +15.4 NA +29.6 -5.7 -8.0 -2.6 -3.8 +0.2 +10.2 -7.9 -5.3 -4.8 -6.1 +8.4 +4.1 
 Trimethoprim +12.0 -1.7 NA +10.3 -1.4 -10.4 -10.8 -9.3 +12.8 +13.9 +6.6 -2.2 +8.4 +19.7 +17.9 +13.8 
 Sulfamethoxazole -13.8 -4.1 NA +14.8 +4.3 +0.7 +10.3 -5.2 -0.8 -3.8 +8.6 -4.8 +3.7 -2.7 -1.0 +7.1 
 Triclosan +5.6 +3.3 NA +0.8 -20.0 +2.7 -13.9 +4.2 -12.0 +5.9 -10.1 -6.1 -2.4 +5.1 -1.7 +5.5 
Hypertension Valsartan +4.3 +5.0 NA +0.6 -7.0 +18.9 -7.9 -4.9 -0.4 -5.8 +2.7 0.0 +2.4 -8.1 -3.0 +7.3 
 Irbesartan +6.7 +2.4 NA -5.1 -9.9 +28.2 -17.0 -2.0 -2.6 0.0 +12.1 +15.6 +1.8 -1.5 +10.5 +16.3 
 Lisinopril +2.6 -3.5 NA +9.6 -4.5 +45.6 +12.4 -9.4 +10.6 -0.5 -3.3 -14.8 +11.7 +0.9 +1.1 +14.3 
NSAIDs Ketoprofen - - NA - - - - - +3.4 +8.9 +6.4 +4.8 -6.3 +10.8 -1.8 +8.0 
 Ibuprofen +0.7 0.0 NA +7.1 +1.3 +0.4 +10.5 -4.9 +1.4 +2.5 +3.8 +1.4 +0.3 +2.7 -3.2 +14.4 
 Naproxen +0.5 +5.2 NA +10.8 +14.3 +5.5 +5.5 -0.8 +2.8 -1.8 +4.2 -4.5 -4.9 -4.1 -6.3 +11.0 
 Diclofenac +2.2 +20.4 NA -1.3 +2.0 +23.4 +1.3 +3.6 -4.3 +11.3 -1.6 +0.5 -3.1 +9.8 +1.0 +15.9 
 Acetaminophen +1.3 -0.3 NA +6.0 +11.0 +16.8 +0.9 +8.1 +16.3 +14.3 +19.5 +13.1 +18.1 +6.8 +6.8 +17.8 
Lipid regulators Bezafibrate -2.2 +2.8 NA +4.2 +9.2 +10.5 +10.4 -6.7 +4.3 -2.8 +13.4 -1.1 +0.6 +0.1 -4.3 +11.1 
 Atorvostatin -5.4 -14.6 NA -21.1 -21.1 -26.2 -11.9 -4.1 -7.1 -19.2 -2.0 -5.8 +2.0 -9.1 +16.5 +12.9 
Antihistamines Fexofenadine -6.1 +4.8 NA +17.5 +22.4 +36.6 -4.9 -12.2 +8.8 +17.8 +11.7 +5.9 +0.8 +7.3 -9.5 +16.6 
 Cetirizine +8.0 +1.7 NA +6.2 +4.1 +7.3 +3.1 0.0 -4.6 +1.2 -3.5 -4.2 +3.7 +5.0 -3.8 +3.0 
Diabetes Metformin -0.1 -1.7 NA +1.9 +3.3 +14.0 -11.4 +0.4 +4.0 -2.2 -0.6 +0.2 +2.2 -1.6 +1.3 -0.7 
 Gliclazide +15.6 +13.7 NA +2.7 -2.2 +14.7 +36.5 -10.4 +2.0 -1.6 -5.7 -16.8 -6.8 +3.3 -3.8 -9.3 
Cough 
suppressant Pholcodine - - NA - - - - - - - - - - - - - 
Beta-blocker Atenolol +5.7 +8.3 NA +3.7 0.0 +7.0 -7.9 +2.8 +2.3 0.0 +0.6 -1.9 +4.8 -1.5 -2.0 -0.1 
 Metoprolol +12.2 +2.5 NA +4.2 -2.8 -12.7 +5.2 0.0 -1.8 0.0 +2.5 0.0 +9.8 +11.3 -7.7 +4.8 
 Propranolol +13.3 +2.9 NA 0.0 -12.9 -11.0 -7.7 -2.3 -3.2 +1.7 +4.0 -8.0 +3.7 -2.4 -0.9 -1.3 
H2 receptor 
agonists Ranitidine +5.1 -0.1 NA +1.8 +1.1 -4.9 -12.2 +0.7 -11.5 -7.7 0.0 -12.9 +0.1 -2.0 -6.3 -4.6 
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 Cimetidine -14.9 +3.9 NA -3.6 -1.7 +37.7 -3.8 +9.8 -19.4 -19.0 +13.1 -3.8 -14.7 -15.9 -9.5 -7.4 
X-ray contrast 
media Iopromide - - NA - - - - - - - - - - - - - 
Drug precursor 
and metabolite Ephedrine/pseudoephedrine +8.3 +5.7 NA +17.1 +18.8 -4.9 +4.8 -5.6 +14.8 +4.5 +5.7 -0.7 +11.8 -3.7 -2.9 +4.9 
 Norephedrine - - NA - - - - - - - - - - - - - 
Anti-cancer Azathioprine - - NA - - - - - - - - - - - - - 
 Methotrexate - - NA - - - - - - - - - - - - - 
 Ifosfamide - - NA - - - - - - - - - - - - - 
 Tamoxifen - - NA - - - - - - - - - - - - - 
Anaesthetic and 
metabolite Ketamine - - NA - - - - - - - - - - - - - 
 Norketamine - - NA - - - - - - - - - - - - - 
Anti-depressants 
and metabolites Venlafaxine +9.7 -0.5 NA -36.2 +8.8 +3.5 +0.8 -7.2 -5.2 -3.7 +5.8 +0.2 -1.5 +0.2 +0.9 +5.3 
 Fluoxetine +67.8 +49.7 NA -1.0 -5.5 +29.5 +12.5 -3.6 -11.2 +15.8 -8.8 -10.2 +5.0 0.0 -14.5 +11.0 
 Norfluoxetine +9.6 +12.5 NA -1.0 -5.2 +6.7 -0.9 -4.6 -3.3 -5.5 -4.4 -6.6 -1.1 +9.5 -3.2 1.1 
 Sertraline +25.8 0.0 NA -10.7 -7.9 -6.1 -8.0 -2.7 -5.6 -5.3 -6.2 -3.0 +8.2 -8.2 -11.0 +5.2 
 Mirtazapine +8.6 +12.6 NA +11.9 +8.9 -18.1 -1.0 -2.7 -2.7 -0.9 -1.0 -0.9 +3.1 -1.8 -7.5 -6.9 
 Citalopram +18.4 +7.5 NA +6.4 +8.8 +5.1 -12.2 -4.5 -6.9 -0.1 -0.5 +2.2 +1.0 0.0 -4.5 -2.7 
 Desmethylcitalopram +13.5 +18.4 NA +29.1 +13.9 +17.5 +0.9 +14.8 -12.4 -7.5 -12.3 -3.2 -16.0 -4.5 +0.6 -5.3 
Anti-epileptic and 
metabolites Carbamazepine +2.8 +0.6 NA -0.2 +7.1 +4.3 +45.4 +3.0 -0.4 +1.7 -4.8 -4.3 -1.5 -0.9 -2.5 -0.2 
 Carbamazepine10,11-epoxide - - NA - - - - - - - - - - - - - 
 10,11-Dihydro-10-hydroxycarbamazepine -4.4 -18.6 NA +14.4 +8.9 -0.5 -7.2 +17.8 +3.5 +19.0 +16.3 -9.3 +9.0 +3.3 -3.4 0.0 
Calcium channel 
blocker Diltiazem +44.1 +16.5 NA +26.8 +30.8 +3.6 +12.3 +8.2 -2.8 +5.7 0.0 -1.7 +2.0 -5.9 -11.1 0.0 
Hypnotic Temazepam +11.5 +2.5 NA +25.0 -10.1 -7.7 -8.7 -12.4 -9.5 +1.5 -8.9 0.0 +8.3 +11.7 -5.6 +9.6 
Anti-psychotic Quetiapine -4.7 +18.1 NA +8.3 -35.0 +8.3 +111 -15.9 -3.3 +6.7 -10.5 -12.5 -4.5 +3.8 -10.3 -14.8 
Veterinary Tylosin - - NA - - - +81.0 -8.3 - - - - - - - - 
Human indicators 
and metabolites Creatinine -1.1 +3.0 NA +16.6 +21.4 +37.3 +4.6 +17.0 +8.4 -16.9 +10.5 +14.2 +17.7 -2.5 +4.9 +14.4 
 Nicotine -5.4 -4.1 NA -12.2 -8.6 -2.7 -3.7 +2.7 -3.2 -14.3 -0.9 +15.8 -17.3 -11.9 -12.0 -19.7 
 Caffeine -15.0 -12.0 NA -20.9 +12.9 +10.1 -9.2 +3.2 +11.0 -8.8 +15.6 +3.8 +10.2 +7.8 -8.4 +7.8 
 Cotinine +2.0 +1.5 NA +4.2 +10.1 -0.1 -0.3 -4.8 +2.6 +5.7 +2.7 -0.8 +4.0 -5.8 +2.8 +5.4 
 1,7 dimethylxantine +8.5 -3.6 NA -2.5 +28.6 +21.1 -3.8 +0.6 +1.1 -6.1 +2.8 -6.0 +4.7 -7.3 -1.2 +7.4 
Analgaesics and 
metabolites Morphine -4.1 -8.9 NA +24.4 +5.4 -5.7 +1.0 -0.9 +4.2 -7.2 +5.1 -3.2 -2.5 -0.6 -0.7 +6.7 
 Dihydromorphine - -16.7 NA - - - - - - - - - - - - - 
 Normorphine -9.3 +8.8 NA +37.6 -23.1 +8.9 -19.5 -11.4 +6.5 -13.5 -7.8 -17.6 +0.9 -11.0 +11.8 +4.6 
 Methadone +11.9 +8.3 NA +10.0 +14.3 0.0 +1.9 -14.9 0.0 0.0 0.0 -4.0 +10.7 -9.1 -7.7 -4.5 
 EDDP +3.2 +6.4 NA -1.8 +11.8 -3.3 -7.6 -3.6 -4.5 -7.3 -3.4 -5.0 -2.6 -2.5 -3.3 +2.7 
 Codeine +2.4 +1.9 NA +9.0 +1.4 -16.9 -4.8 -2.3 +10.8 +2.4 +5.5 -5.0 +5.5 -3.4 +1.4 +1.8 
 Norcodeine +13.5 +2.0 NA +15.2 +17.2 -19.5 -7.3 -23.7 +16.1 +9.2 +13.6 -1.0 +2.9 +5.5 +5.1 +7.7 
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 Dihydrocodeine +1.0 +1.2 NA +14.4 -4.2 -18.5 -6.4 -5.6 +5.7 +11.6 +5.7 +10.1 +9.6 +11.3 +13.3 +15.3 
 Tramadol +3.2 +2.4 NA +15.0 +12.3 -9.3 -4.6 -3.2 -9.5 -6.4 +3.9 +2.1 -2.4 +1.4 -3.3 +3.8 
 N-desmethyltramadol +5.7 -19.1 NA -8.5 -9.1 +9.4 -25.3 -17.7 -3.9 -2.8 +3.6 -4.0 +3.3 -1.4 -2.5 -6.2 
 O-desmethyltramadol +20.8 -0.7 NA +6.5 +10.2 +17.4 -10.0 -1.5 +17.0 +17.7 +15.1 -0.1 +14.7 +9.4 +9.0 +5.2 
Stimulants and 
metabolites Amphetamine -4.2 +3.3 NA +9.9 +5.8 -5.5 -2.4 -0.2 +14.1 +6.2 -13.2 -17.0 +2.3 +14.7 +15.2 +9.6 
 Methamphetamine +4.5 -4.8 NA +5.3 +6.3 0.0 -4.3 +3.8 0.0 0.0 0.0 +7.1 -18.8 0.0 0.0 0.0 
 MDMA +2.8 -8.8 NA -6.2 +30.7 +9.8 -13.4 -1.6 -3.4 -2.4 -1.1 +3.4 +3.5 -2.7 -3.0 +0.9 
 MDA - - NA - - - - - 0.0 5.3 0.0 -8.3 0.0 -5.2 -1.7 12.6 
 Cocaine +10.4 -0.9 NA -0.8 +46.8 +1.9 -1.2 +0.6 -2.8 -0.4 0.0 +0.9 -1.6 +0.8 -1.2 +0.8 
 Benzoylecgonine -1.7 +2.1 NA +8.9 +21.8 +8.3 -8.9 -2.8 -3.3 -4.6 -2.8 -1.6 +6.0 -0.4 +1.6 +0.3 
 Anhydroecgonine methylester - - NA - - - - - - - - - - - - - 
 Cocaethylene - - NA - - +25.4 -14.3 - - - - - - +12.5 +16.7 - 
 Mephedrone -21.4 +4.2 NA - - +5.0 - - - - - - - - - - 
 MDPV - - NA - - - - - - - - - - - - - 
Opioid and 
metabolite Heroin - - NA - - - - - - - - - - - - - 
 6-acetylmorphine -36.8 - NA - - - - - - - - - - - - - 
Key: NA, not available due to malfunction of the time composite sampler; -, concentration <MQL 
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Table S10.  Frequency of detection, minimum, maximum and median concentration of micropollutants in grab samples of influent and effluent wastewater 
Micropollutant class Micropollutant 























UV filters Benzophenone-1 100 60.4 152.8 89.5 27.3 0 - - - - 
 Benzophenone-2 0 - - - - 0 - - - - 
 Benzophenone-3 100 207.1 620.6 331.8 27.1 100 118.2 205.0 166.9 16.8 
 Benzophenone-4 100 1,858 9,524 4,030 46.6 100 1,682 4,739 2,239 25.9 
Parabens Methylparaben 100 958.2 6,104 2,896 45.7 100 22.4 43.2 28.3 20.7 
 Ethylparaben 100 126.1 1,185 483.3 52.7 100 3.9 8.8 6.9 19.7 
 Propylparaben 100 299.7 1,868 1,226 41.8 100 2.9 23.1 6.9 62.6 
 Butylparaben 100 5.2 117.8 81.9 50.9 0 - - - - 
Plasticizer Bisphenol-A 100 465.6 946.4 847.2 49.2 100 57.4 201.5 102.1 34.7 
Steroid estrogens E1 100 26.2 76.2 51.9 27.8 100 14.3 30.7 25.0 17.3 
 E2 0 - - - - 0 - - - - 
 EE2 0 - - - - 0 - - - - 
Antibacterials/ 
antibiotics Sulfasalazine 100 57.4 537.9 180.8 60.7 100 45.2 88.6 65.3 17.0 
 Clarithromycin 100 547.0 3,234 860.6 65.3 100 1,404 2,761 2,012 22.5 
 Azithromycin 100 52.0 283.5 141.2 58.4 100 84.5 147.5 124.4 14.6 
 Trimethoprim 100 931.5 2,124 1,229 28.9 100 554.0 1,104 839.8 14.5 
 Sulfamethoxazole 100 64.5 1,154 192.0 94.7 100 23.0 188.8 120.5 33.1 
 Triclosan 100 339.0 2,359 1,579 45.2 100 96.4 461.9 297.2 31.5 
Hypertension Valsartan 100 187.4 939.1 476.9 44.3 100 151.5 380.4 270.1 20.5 
 Irbesartan 100 93.1 268.1 138.8 37.0 100 14.1 98.1 71.7 30.0 
 Lisinopril 100 200.2 526.9 311.9 25.8 100 120.6 228.1 166.0 15.4 
NSAIDs Ketoprofen 0 - - - - 100 15.2 64.0 42.0 33.6 
 Ibuprofen 100 4,016 20,215 16,266 32.5 100 1,746 3,718 2,943 20.1 
 Naproxen 100 6,985 20,398 15,824 33.1 100 3,291 6,412 5,368 18.4 
 Diclofenac 100 239.9 1,881 687.3 59.5 100 239.4 521.2 387.8 21.6 
 Acetaminophen 100 171,875 512,813 347,250 29.6 100 692.0 2,195 1,092 30.9 
Lipid regulators Bezafibrate 100 544.6 2,032 1,336 38.7 100 511.9 874.0 734.0 14.9 
 Atorvostatin 100 216.5 788.5 382.0 35.6 100 69.0 233.0 142.5 25.3 
Antihistamines Fexofenadine 100 568.3 4,555 1,686 53.9 100 341.5 632.5 525.7 16.7 
 Cetirizine 100 954.4 2,333 1,868 25.8 100 302.5 470.8 402.1 12.9 
Diabetes Metformin 100 43,582 98,706 74,002 24.4 100 13,754 29,881 25,000 20.2 
 Gliclazide 100 50.3 276.4 68.6 62.9 100 57.9 91.4 73.7 10.3 
Cough suppressant Pholcodine 0 - - - - 0 - - - - 
Beta-blocker Atenolol 100 1,168 3,423 2,466 26.6 100 591.4 966.8 788.2 13.7 
 Metoprolol 100 8.6 109.1 18.8 93.6 100 10.7 21.8 14.2 15.9 
 Propranolol 100 83.1 269.7 154.0 33.7 100 60.9 102.7 75.7 13.0 
H2 receptor agonists Ranitidine 100 1,130 3,943 1,799 40.5 100 829.8 2,116 1,574 20.0 
 Cimetidine 100 43.3 1,114 136.1 119.2 100 6.8 76.1 55.5 31.2 
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X-ray contrast media Iopromide 12 <123 1,441 <123 - 0 - - - - 
Drug precursor and 
metabolite Ephedrine/pseudoephedrine 100 327.5 955.5 627.5 26.9 100 141.0 227.0 178.5 11.3 
 Norephedrine 0 - - - - 0 - - - - 
Anti-cancer Azathioprine 0 - - - - 0 - - - - 
 Methotrexate 0 - - - - 0 - - - - 
 Ifosfamide 0 - - - - 0 - - - - 
 Tamoxifen 0 - - - - 0 - - - - 
Anaesthetic and 
metabolite Ketamine 6 <1.2 30.0 <1.2 - 0 - - - - 
 Norketamine 0 - - - - 0 - - - - 
Anti-depressants and 
metabolites Venlafaxine 100 119.2 642.9 288.4 51.0 100 170.5 251.4 215.1 9.8 
 Fluoxetine 100 36.0 436.5 87.5 80.2 100 33.0 66.5 44.8 19.6 
 Norfluoxetine 100 29.5 46.0 34.0 14.4 100 26.5 34.5 30.5 6.2 
 Sertraline 100 35.5 104.0 42.5 33.1 100 13.5 44.5 28.0 21.8 
 Mirtazapine 100 33.0 105.5 68.5 31.7 100 30.5 40.0 35.8 8.2 
 Citalopram 100 239.0 509.5 440.0 20.4 100 189.0 270.5 235.5 8.6 
 Desmethylcitalopram 100 37.0 172.5 166.5 35.0 100 17.0 57.5 34.8 28.5 
Anti-epileptic and 
metabolites Carbamazepine 100 168.6 367.0 244.7 23.1 100 134.7 175.8 156.0 8.0 
 Carbamazepine10,11-epoxide 0 - - - - 0 - - - - 
 10,11-Dihydro-10-hydroxycarbamazepine 88 <9.9 564.0 157.5 95.0 92 <8.4 84.0 47.5 53.5 
Calcium channel 
blocker Diltiazem 100 87.5 399.0 180.8 39.8 100 8.3 29.2 21.4 27.5 
Hypnotic Temazepam 100 49.5 205.0 99.5 38.3 100 15.4 25.9 21.0 15.9 
Anti-psychotic Quetiapine 100 9.5 57.5 30.5 47.2 100 7.0 21.0 11.0 33.1 
Veterinary Tylosin 0 - - - - 0 - - - - 
Human indicators and 
metabolites Creatinine 100 320,562 2,400,438 1,182,313 46.7 100 9,938 29,000 14,500 32.1 
 Nicotine 100 7,313 9,000 8,188 6.8 100 116.0 196.0 161.3 14.4 
 Caffeine 100 41,625 230,562 190,938 46.8 100 1,125 18,688 5,313 68.8 
 Cotinine 100 1,153 2,191 2,029 18.7 100 367.0 562.5 487.3 12.0 
 1,7 dimethylxantine 100 52,938 133,313 115,875 26.1 100 5,813 19,188 9,313 32.2 
Analgaesics and 
metabolites Morphine 100 640.0 1,618 1,209 22.6 100 293.0 504.0 418.0 11.3 
 Dihydromorphine 0 - - - - 0 - - - - 
 Normorphine 100 62.0 177.0 146.0 25.1 100 16.5 60.5 36.5 26.3 
 Methadone 100 19.5 62.5 36.5 29.4 100 3.0 24.5 8.8 50.0 
 EDDP 100 78.0 161.5 121.5 20.0 100 50.5 75.0 64.5 9.6 
 Codeine 100 1,023 2,801 1,654 28.2 100 761.5 1,198.0 991.3 11.4 
 Norcodeine 100 90.5 169.0 115.5 19.7 100 73.0 120.0 98.5 13.0 
 Dihydrocodeine 100 151.5 384.5 224.0 29.6 100 166.0 221.0 191.0 7.6 
 Tramadol 100 448.0 913.0 593.5 18.1 100 422.5 716.5 590.8 13.5 
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 N-desmethyltramadol 100 178.0 491.0 346.0 29.0 100 91.5 163.5 123.8 15.4 
 O-desmethyltramadol 100 465.5 1,193 907.0 23.9 100 6.8 76.1 55.5 17.3 
Stimulants and 
metabolites Amphetamine 100 271.0 543.5 434.0 17.4 100 24.5 81.5 52.5 31.6 
 Methamphetamine 100 4.5 17.5 6.5 42.4 100 5.0 6.5 6.0 9.2 
 MDMA 100 93.0 385.5 188.0 39.8 100 67.5 114.5 85.0 12.8 
 MDA 0 - - - - 100 6.5 12.5 9.3 17.4 
 Cocaine 100 189.5 367.5 264.0 20.9 100 74.5 131.5 87.3 18.8 
 Benzoylecgonine 100 739.5 2,617 1,139 35.6 100 348.5 511.0 417.8 11.2 
 Anhydroecgonine methylester 0 - - - - 0 - - - - 
 Cocaethylene 47 <6.5 25.0 10.0 49.0 0 - - - - 
 Mephedrone 65 <2.8 136.5 17.0 174.6 0 - - - - 
 MDPV 0 - - - - 0 - - - - 
Opioid and metabolite Heroin 0 - - - - 0 - - - - 
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